Is now the time to buy quantum stocks? If so, which ones? There is no evidence-based universal answer or clear winner: pure-play quantum companies remain early in commercialization, and their shares have been highly volatile. IonQ and Rigetti offer more concentrated exposure; larger technology companies pursue quantum research alongside broader businesses. Before buying, weigh the current share price against commercial progress, losses, financing needs, and the chance that useful applications take longer than expected. The available evidence does not establish a fair value or a best entry price for any candidate.
What buying a quantum stock means
Quantum computing is a developing technology, not yet a mature market with predictable, broad-based sales. A stock purchase is therefore a bet on a company’s ability to turn technical work into repeatable commercial demand—and on the market not having already priced in too much success.
As an Amazon Associate I earn from qualifying purchases.
Exposure varies by company. A pure-play developer can make quantum progress or setbacks a more direct driver of its share price. At a diversified technology company, quantum research sits alongside much larger businesses, so it represents a smaller part of the overall investment case. Rigetti’s FY2025 Form 10-K names IBM, Google, Microsoft, IonQ, D-Wave, and Quantinuum among developers or competitors; Amazon is also investing in quantum research.
Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minutePC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11That distinction changes the risk, but not the need to assess price. A company can make technical progress and still be a poor investment if it cannot commercialize, needs substantial additional financing, or is valued as if future success were already assured.
What the latest company evidence does—and doesn’t—show
Reported results, orders, and management forecasts are different kinds of evidence. Revenue and losses describe a past period; an order indicates a customer commitment but not necessarily recurring demand; guidance is a forecast, not a result.
IonQ: rapid reported growth alongside a large loss
IonQ reported revenue of USD 80.1 million for the quarter ended June 30, 2026, up 287% year over year. It also reported a GAAP net loss of USD 1,867.7 million for that quarter. The company reported USD 3.0 billion in cash, cash equivalents, and investments as of June 30, 2026. Those figures belong together when assessing the business: growth is meaningful, but it does not by itself establish profitability, recurring demand, or an attractive stock price. (IonQ, Q2 2026 results.)
IonQ’s August FY2026 revenue outlook was USD 280 million to USD 290 million and excluded contributions from SkyWater. On September 8, after acquiring SkyWater on July 31, IonQ raised its FY2026 outlook to USD 450 million to USD 460 million, including SkyWater from the acquisition date. The two forecasts are not directly comparable as measures of IonQ’s underlying growth because the later one includes the acquired business. Both are forward-looking company guidance, not achieved revenue.
Free tools Windows power users keep installed
One-click scans. No signup required.
Rigetti: an order is not proof of a repeatable business
Rigetti’s FY2025 Form 10-K says most of its current revenue comes from technology-development contracts. The company describes quantum processor and system sales, as well as cloud access, as parts of its longer-term business model. The filing reports an USD 8.4 million purchase order for a 108-qubit system for India’s C-DAC, with installation and deployment expected in the second half of 2026. That is evidence of a sale, but one order does not establish a pattern of repeat purchases, profitable scaling, or technical advantage.
For both companies, look beyond headline growth or a hardware specification. Ask whether systems are delivered and used, whether customers return, what portion of revenue is recurring, and how much funding the company may need before its business can support itself.
How to compare quantum stocks
Quantum companies compete on more than a single qubit count or technical announcement. Rigetti’s filing identifies performance—including scale, speed, and fidelity—accessibility, software and applications, compatibility with classical workflows, innovation, price, financial resources, and customer support as competitive factors. Investors can use those categories alongside business and valuation checks:
Rank #4
- Technical scaling: Look for evidence that performance can improve as systems scale, and consider whether the company’s claims have been independently validated. A milestone is not the same as a commercially useful, fault-tolerant system.
- Customer evidence: Distinguish a research contract, announced order, deployment, ongoing utilization, and repeat purchase. Each is a different point on the path to durable demand.
- Revenue quality: Identify whether revenue comes from development work, system sales, cloud access, or other services. Check whether reported growth reflects existing operations or an acquisition.
- Financial runway and dilution: Compare cash and investments with losses and spending needs, then consider whether additional borrowing or share issuance may be required. A large cash balance at one date does not guarantee long-term funding sufficiency.
- Valuation: Compare the market price and company valuation with plausible commercial outcomes, not only with technical potential or management forecasts. The available evidence does not provide a same-date valuation comparison or a current fair value for these candidates.
- Concentration: Consider what happens to the whole portfolio if one company misses a technical or commercial milestone. A single-company position concentrates company-specific risk.
There is not enough comparable evidence here to rank IonQ and Rigetti as investments. IonQ’s reported quarter provides recent revenue, loss, and cash figures; Rigetti’s filing gives detail about revenue sources and a specific order. Those facts illuminate different parts of each business, not a complete, same-date head-to-head valuation or a reason to prefer one share.
Recommended Free Tools
Are quantum stocks too risky?
They can be unsuitable for investors who need the money soon, cannot tolerate sharp losses, or would have an uncomfortably concentrated portfolio if a position fell steeply. ESMA’s May 13, 2026 analysis describes pure-play firms as early in commercialization and still operating at significant losses. It also records repeated share-price surges and corrections since late 2024.
Best Value
ESMA reported that the combined market value of four selected quantum-focused companies briefly exceeded USD 65 billion, while weekly trading volumes passed USD 70 billion in late 2025. These are historical measures from ESMA, not current prices, valuations, or a signal that shares are cheap or expensive today. A fast-moving market can magnify both optimism and reversals.
There is no established schedule in the evidence here for when commercially useful, fault-tolerant quantum computing will arrive. Technical milestones and company guidance cannot reliably answer that timing question. Treat quantum exposure as speculative, and only consider it in light of your time horizon, ability to absorb a loss, and the rest of your portfolio.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Would a quantum ETF be less risky?
A fund can reduce dependence on any one company, but a quantum-themed ETF is not automatically low risk or broadly diversified across the economy. ESMA’s May 2026 analysis describes funds with differing mixes of pure-play quantum companies, large technology developers, and suppliers. A fund’s holdings and methodology determine what exposure it actually provides.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
For the US, ESMA reported USD 3.3 billion in assets under management for a quantum-computing and machine-learning-themed ETF and USD 0.03 billion for a recently launched pure-play quantum fund, as of the report’s stated March 2026 period. These are dated AUM figures, not current fund sizes or measures of future performance. Before considering a fund, check its current holdings and concentration, fees, liquidity, index or active methodology, and availability in your jurisdiction. A fund focused on one emerging theme can still fall sharply if that theme loses favor.
A practical decision before placing an order
- Set a portfolio limit. Decide in advance how much speculative exposure you can afford to lose without undermining near-term goals or essential savings.
- Choose the exposure type. Decide whether you want concentrated company risk or a fund whose holdings may span pure-play developers, diversified technology businesses, and suppliers.
- Read the latest filings and results. Check reported revenue, losses, cash, financing needs, customer concentration, and the source of revenue. Separate actual results from forecasts and acquisition effects.
- Test the commercial case. Look for delivered systems, customer use, repeat business, and a credible route to recurring revenue—not just technical announcements or an order.
- Check the price you would pay. A strong technology story is not a valuation analysis. Review current market capitalization and share price against the company’s risks and plausible outcomes before deciding whether to buy, wait, or pass.
For personal financial decisions, the right choice depends on circumstances the company disclosures cannot supply, including your goals, risk capacity, and existing investments. This is general information, not individualized financial advice.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
